cp wire

CP Wire Articles

Takeda Pharmaceutical Company Limited (“Takeda”) announce on 7/10/18 that it has received unconditional clearance from the United States Federal Trade Commission (“FTC”) for the proposed... read more

Tue, 07/10/18 - 09:49 am
CP Staff
  • New site will enable the company to respond to the growing global demand for foot-and-mouth disease and Bluetongue virus control
  • It represents a record investment into the company’s... read more
Tue, 07/10/18 - 09:42 am
CP Staff
  • BPN14770 has received orphan drug designation
  • Also in trials for Alzheimer's and traumatic brain injury
  • Ph I trials showed excellent safety and improved cognitive capability... read more
Tue, 07/10/18 - 09:27 am
CP Staff
  • Eagle believes orphan drug status will also prevent Treanda generics until 2020
  • FDA asked court to clarify that order related to Bendeka and orphan drug status does not affect... read more
Mon, 07/9/18 - 09:32 am
CP Staff
  • Plans to initiate trial in second half of 2018
  • Edasalonexent significantly slowed progression in Ph II trial
  • Edasalonexent is being developed as monotherapy or for use in... read more
Mon, 07/9/18 - 09:04 am
CP Staff

On April 6, 2018, BioGaia became the majority shareholder in MetaboGen with a 62 percent stake. After certain milestones were achieved, BioGaia has extended its ownership to 92 percent of the... read more

Fri, 07/6/18 - 11:49 am
CP Staff
  • There is concern that smallpox could be used as a bioweapon
  • TPOXX was effective in animal models
  • Target PDUFA date is August 8, 2018

SIGA Technologies,... read more

Thu, 07/5/18 - 09:02 am
CP Staff

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that, following receipt of regulatory approvals, it has completed the previously announced agreement to acquire a 40 percent minority... read more

Thu, 07/5/18 - 08:46 am
CP Staff
  • Bendeka has Orphan Drug Exclusivity until Dec. 2022
  • Company does not expect generic entrants of previous version of Bendeka until Dec. 2022
  • Teva is responsible for all US... read more
Tue, 07/3/18 - 09:54 am
CP Staff

With the recent FDA approval of Epidiolex(marijuana derived cannabidiol (CBD)), a number of questions have been asked about how... read more
Mon, 07/2/18 - 04:40 pm
admin


Arrayit Corporation (OTC: ARYC) announced on 7/02/2018 that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores.  The retailer... read more

Mon, 07/2/18 - 09:46 am
CP Staff



Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a... read more

Mon, 07/2/18 - 09:26 am
CP Staff
  • Application based on data from PH III KEYNOTE-407 trial
  • PDUFA target date set for 10/30/2018


Merck (NYSE:MRK) announced on 7/02/2018 that the U.S. Food and Drug... read more

Mon, 07/2/18 - 09:16 am
CP Staff

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) announced on 6/29/2018 detailed data from the ADVANCE Phase 3 study which showed that Rolontis had an absolute risk reduction of severe neutropenia... read more

Fri, 06/29/18 - 09:58 am
CP Staff



Kite, a Gilead Company (Nasdaq: GILD) announced on 6/29/2018 that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion... read more

Fri, 06/29/18 - 09:42 am
CP Staff

Argenx (Euronext & Nasdaq: ARGX) announced on 6/28/2018 the achievement of the second of two preclinical milestones towards... read more

Thu, 06/28/18 - 09:57 am
CP Staff

Arsanis, Inc. (NASDAQ:ASNS) announced on 6/28/2018 the discontinuation of its Phase 2 clinical trial of ASN100 for the prevention of S. aureuspneumonia in high-risk, mechanically ventilated... read more

Thu, 06/28/18 - 09:43 am
CP Staff
  • Combined company will be named Akebia Therapeutics, Inc.
  • Company will focus on patients with chronic kidney disease
  • Combined portfolio can address the needs of an estimated... read more
Thu, 06/28/18 - 09:17 am
CP Staff

Cedilla Therapeutics  announced on 6/28/2018 the appointment of three vice presidents with extensive experience in drug discovery to advance the company’s mission of harnessing existing protein... read more

Thu, 06/28/18 - 09:05 am
CP Staff

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.